BIT
ADMS

BlackRock Institutional Trust’s Adamas Pharmaceuticals ADMS Stock Holding History

BlackRock Institutional Trust’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.9M Buy
349,005
+54,405
+18% +$841K ﹤0.01% 2663
2016
Q3 		$4.83M Buy
294,600
+25,613
+10% +$389K ﹤0.01% 2705
2016
Q2 		$4.07M Buy
268,987
+35,386
+15% +$583K ﹤0.01% 2776
2016
Q1 		$3.38M Buy
233,601
+52,341
+29% +$881K ﹤0.01% 2830
2015
Q4 		$5.13M Buy
181,260
+17,261
+11% +$291K ﹤0.01% 2708
2015
Q3 		$2.75M Buy
163,999
+46,312
+39% +$1.05M ﹤0.01% 2990
2015
Q2 		$3.09M Buy
117,687
+87,918
+295% +$1.71M ﹤0.01% 2946
2015
Q1 		$521K Buy
29,769
+5,776
+24% +$99K ﹤0.01% 3496
2014
Q4 		$417K Sell
23,993
-651
-3% -$9.88K ﹤0.01% 3530
2014
Q3 		$459K Sell
24,644
-5,233
-18% -$90K ﹤0.01% 3506
2014
Q2 		$546K Buy
+29,877
New +$535K ﹤0.01% 3550

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock Institutional Trust's ADMS Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Adamas Pharmaceuticals (ADMS) stake by 18% in Q4 2016, buying an estimated $841K and bringing the position to 349,005 shares worth $5.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2663.

BlackRock Institutional Trust first reported a position in ADMS in Q2 2014 and has held it in 11 quarters since. 78 funds tracked by Wall St. Rank hold ADMS as of Q4 2016.

  • BlackRock Institutional Trust held 349,005 shares of Adamas Pharmaceuticals worth $5.9M as of Q4 2016.
  • BlackRock Institutional Trust bought 54,405 Adamas Pharmaceuticals shares in Q4 2016, an estimated $841K.
  • Adamas Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2663 holding.
  • BlackRock Institutional Trust first reported a position in Adamas Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
  • 78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.